Short interest in Oramed Pharmaceuticals Inc (NASDAQ:ORMP) increased during the last reporting period, rising from 298.47K to 299.98K. This put 0.81% of the company's publicly available shares short.

Short interest for Oramed Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Oramed Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 66.31K shares traded per day, it would take 4.52 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.